Non-24-hour Sleep-wake Disorder Treatment - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the Latest Research Report,, the global market for Non-24-hour Sleep-wake Disorder Treatment should grow from US$ 480 million in 2022 to US$ 726.1 million by 2029, with a CAGR of 6.1% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Non-24-hour Sleep-wake Disorder Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Non-24-hour Sleep-wake Disorder Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital Pharmacies grew percent to account for percent of the total market sales, and Retail Pharmacies grew percent.
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
This report studies and analyses global Non-24-hour Sleep-wake Disorder Treatment status and future trends, to help determine the Non-24-hour Sleep-wake Disorder Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Non-24-hour Sleep-wake Disorder Treatment, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Non-24-hour Sleep-wake Disorder Treatment market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Non-24-hour Sleep-wake Disorder Treatment by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Non-24-hour Sleep-wake Disorder Treatment by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Non-24-hour Sleep-wake Disorder Treatment key consuming regions, consumption value and demand structure
(5) Non-24-hour Sleep-wake Disorder Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Market segment by Type, covers
Prescription Drugs
OTC
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Other
Key Regions Covered in This Report Are:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Non-24-hour Sleep-wake Disorder Treatment product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Non-24-hour Sleep-wake Disorder Treatment market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Non-24-hour Sleep-wake Disorder Treatment market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Non-24-hour Sleep-wake Disorder Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Non-24-hour Sleep-wake Disorder Treatment Definition
1.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast
1.3 China Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Non-24-hour Sleep-wake Disorder Treatment Market Size: China VS Global Growth Rate, 2018-2029
1.6 Non-24-hour Sleep-wake Disorder Treatment Market Dynamics
1.6.1 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
1.6.2 Non-24-hour Sleep-wake Disorder Treatment Market Restraints
1.6.3 Non-24-hour Sleep-wake Disorder Treatment Industry Trends
1.6.4 Non-24-hour Sleep-wake Disorder Treatment Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Non-24-hour Sleep-wake Disorder Treatment, Global Market Share by Company, 2018-2023
2.2 Global Non-24-hour Sleep-wake Disorder Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Non-24-hour Sleep-wake Disorder Treatment Concentration Ratio
2.4 Global Non-24-hour Sleep-wake Disorder Treatment Mergers & Acquisitions, Expansion Plans
2.5 Global Non-24-hour Sleep-wake Disorder Treatment Major Companies Product Type
2.6 Head Office and Non-24-hour Sleep-wake Disorder Treatment Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Non-24-hour Sleep-wake Disorder Treatment, China Market Share by Company, 2018-2023
3.2 China Non-24-hour Sleep-wake Disorder Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain
4.2 Non-24-hour Sleep-wake Disorder Treatment Upstream Analysis
4.2.1 Non-24-hour Sleep-wake Disorder Treatment Core Raw Materials
4.2.2 Main Manufacturers of Non-24-hour Sleep-wake Disorder Treatment Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Non-24-hour Sleep-wake Disorder Treatment Production Mode
4.6 Non-24-hour Sleep-wake Disorder Treatment Procurement Model
4.7 Non-24-hour Sleep-wake Disorder Treatment Industry Sales Model and Sales Channels
4.7.1 Non-24-hour Sleep-wake Disorder Treatment Sales Model
4.7.2 Non-24-hour Sleep-wake Disorder Treatment Typical Distributors
5 Sights by Type
5.1 Non-24-hour Sleep-wake Disorder Treatment Classification
5.1.1 Prescription Drugs
5.1.2 OTC
5.2 By Type, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029
6 Sights by Application
6.1 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
6.1.1 Hospital Pharmacies
6.1.2 Retail Pharmacies
6.1.3 Other
6.2 By Application, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Non-24-hour Sleep-wake Disorder Treatment & Forecasts, 2018-2029
7.3.2 By Country, North America Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.4 Europe
7.4.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.6 South America
7.6.1 South America Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Non-24-hour Sleep-wake Disorder Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.3.2 By Type, U.S. Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.4.2 By Type, Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.5.2 By Type, China Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.6.2 By Type, Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.7.2 By Type, South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.9.2 By Type, India Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Teva
9.1.1 Teva Company Information, Head Office, Market Area and Industry Position
9.1.2 Teva Company Profile and Main Business
9.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.1.4 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.1.5 Teva Recent Developments
9.2 Mylan
9.2.1 Mylan Company Information, Head Office, Market Area and Industry Position
9.2.2 Mylan Company Profile and Main Business
9.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.2.4 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.2.5 Mylan Recent Developments
9.3 Nature’s Bounty
9.3.1 Nature’s Bounty Company Information, Head Office, Market Area and Industry Position
9.3.2 Nature’s Bounty Company Profile and Main Business
9.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.3.5 Nature’s Bounty Recent Developments
9.4 Otsuka Pharma (Pharmavite)
9.4.1 Otsuka Pharma (Pharmavite) Company Information, Head Office, Market Area and Industry Position
9.4.2 Otsuka Pharma (Pharmavite) Company Profile and Main Business
9.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.4.4 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.4.5 Otsuka Pharma (Pharmavite) Recent Developments
9.5 Boiron
9.5.1 Boiron Company Information, Head Office, Market Area and Industry Position
9.5.2 Boiron Company Profile and Main Business
9.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.5.4 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.5.5 Boiron Recent Developments
9.6 Miers Laboratories
9.6.1 Miers Laboratories Company Information, Head Office, Market Area and Industry Position
9.6.2 Miers Laboratories Company Profile and Main Business
9.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.6.4 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.6.5 Miers Laboratories Recent Developments
9.7 Genexa
9.7.1 Genexa Company Information, Head Office, Market Area and Industry Position
9.7.2 Genexa Company Profile and Main Business
9.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.7.4 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.7.5 Genexa Recent Developments
9.8 Homeocan
9.8.1 Homeocan Company Information, Head Office, Market Area and Industry Position
9.8.2 Homeocan Company Profile and Main Business
9.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.8.4 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.8.5 Homeocan Recent Developments
9.9 Clinigen Group
9.9.1 Clinigen Group Company Information, Head Office, Market Area and Industry Position
9.9.2 Clinigen Group Company Profile and Main Business
9.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.9.4 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.9.5 Clinigen Group Recent Developments
9.10 Vanda Pharma
9.10.1 Vanda Pharma Company Information, Head Office, Market Area and Industry Position
9.10.2 Vanda Pharma Company Profile and Main Business
9.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Models, Specifications and Application
9.10.4 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, 2018-2023
9.10.5 Vanda Pharma Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Non-24-hour Sleep-wake Disorder Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Non-24-hour Sleep-wake Disorder Treatment Market Restraints
Table 3. Non-24-hour Sleep-wake Disorder Treatment Market Trends
Table 4. Non-24-hour Sleep-wake Disorder Treatment Industry Policy
Table 5. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Mergers & Acquisitions, Expansion Plans
Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Non-24-hour Sleep-wake Disorder Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Non-24-hour Sleep-wake Disorder Treatment Upstream (Raw Materials)
Table 14. Global Non-24-hour Sleep-wake Disorder Treatment Typical Customers
Table 15. Non-24-hour Sleep-wake Disorder Treatment Typical Distributors
Table 16. By Type, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2018-2029
Table 23. Teva Company Information, Head Office, Market Area and Industry Position
Table 24. Teva Company Profile and Main Business
Table 25. Teva Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 26. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Teva Recent Developments
Table 28. Mylan Company Information, Head Office, Market Area and Industry Position
Table 29. Mylan Company Profile and Main Business
Table 30. Mylan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 31. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Mylan Recent Developments
Table 33. Nature’s Bounty Company Information, Head Office, Market Area and Industry Position
Table 34. Nature’s Bounty Company Profile and Main Business
Table 35. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 36. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Nature’s Bounty Recent Developments
Table 38. Otsuka Pharma (Pharmavite) Company Information, Head Office, Market Area and Industry Position
Table 39. Otsuka Pharma (Pharmavite) Company Profile and Main Business
Table 40. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 41. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Otsuka Pharma (Pharmavite) Recent Developments
Table 43. Boiron Company Information, Head Office, Market Area and Industry Position
Table 44. Boiron Company Profile and Main Business
Table 45. Boiron Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 46. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Boiron Recent Developments
Table 48. Miers Laboratories Company Information, Head Office, Market Area and Industry Position
Table 49. Miers Laboratories Company Profile and Main Business
Table 50. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 51. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Miers Laboratories Recent Developments
Table 53. Genexa Company Information, Head Office, Market Area and Industry Position
Table 54. Genexa Company Profile and Main Business
Table 55. Genexa Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 56. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Genexa Recent Developments
Table 58. Homeocan Company Information, Head Office, Market Area and Industry Position
Table 59. Homeocan Company Profile and Main Business
Table 60. Homeocan Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 61. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Homeocan Recent Developments
Table 63. Clinigen Group Company Information, Head Office, Market Area and Industry Position
Table 64. Clinigen Group Company Profile and Main Business
Table 65. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 66. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Clinigen Group Recent Developments
Table 68. Vanda Pharma Company Information, Head Office, Market Area and Industry Position
Table 69. Vanda Pharma Company Profile and Main Business
Table 70. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Models, Specifications, and Application
Table 71. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Vanda Pharma Recent Developments
List of Figures
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Picture
Figure 2. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Non-24-hour Sleep-wake Disorder Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Non-24-hour Sleep-wake Disorder Treatment Market Share of Global, 2018-2029
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Non-24-hour Sleep-wake Disorder Treatment Key Participants, Market Share, 2022
Figure 7. Non-24-hour Sleep-wake Disorder Treatment Industry Chain
Figure 8. Non-24-hour Sleep-wake Disorder Treatment Procurement Model
Figure 9. Non-24-hour Sleep-wake Disorder Treatment Sales Model
Figure 10. Non-24-hour Sleep-wake Disorder Treatment Sales Channels, Direct Sales, and Distribution
Figure 11. Prescription Drugs
Figure 12. OTC
Figure 13. By Type, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2018-2029
Figure 15. Hospital Pharmacies
Figure 16. Retail Pharmacies
Figure 17. Other
Figure 18. By Application, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 19. By Application, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2018-2029
Figure 20. By Region, Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2018-2029
Figure 21. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022
Figure 23. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022
Figure 25. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022
Figure 27. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022
Figure 29. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 31. By Type, U.S. Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 33. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 36. China Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, China Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, China Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 39. Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 42. South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 45. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 48. India Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, India Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, India Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 51. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share, 2022 VS 2029
Figure 54. Research Methodology
Figure 55. Breakdown of Primary Interviews
Figure 56. Bottom-up and Top-down Approaches
Figure 57. Top-down Approaches
Research Methodology:
Non-24-hour Sleep-wake Disorder Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|